Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: An Age-Old Tale with a New Twist
Emory Cardiology Friday Fellows Conference 05-14-2021 Speaker: Anurag Mehta, MD

▶︎
Sex Differences in Outcomes After LVAD Implant

▶︎
From Evidence to Action: Implementing the 2026 Dyslipidemia Guidelines in Clinical Practice

▶︎
Lipoprotein(a): Who's Most at Risk

▶︎
Lipids 2024 Update

▶︎
Empower Lp(a) – Beyond genetics: The interplay of lifestyle & Lp(a) in cardiovascular health

▶︎
Lp(a) Explained: Genetics, Risk, and What You Can Actually Do

▶︎
Antineoplastic Agents | Clinical Medicine

▶︎
CNS Infections | Clinical Medicine

▶︎
Advances in Lipoprotein (a) | Cardiology Grand Rounds

▶︎
High Lp(a)? Here's What Works (And What Doesn't)

▶︎
Type 2 Diabetes Academy: Advancing Kidney Health in Diabetes

▶︎
Is High LDL Cholesterol Actually Dangerous? The Evidence, The Myths, The Truth

▶︎
2020 FH Global Summit Session 4: Lp(a) and Drivers of Inherited Risk

▶︎
Advanced Treatment Options for Atrial Fibrillation with Dr. Charles Joyner

▶︎
The Heart Attack You Won't See Coming (Even With 'Good' Stats).

▶︎
A Masterclass on Cardiovascular Risk: Decoding Lipoprotein(a) | Dr Dayspring | The Proof EP #320

▶︎
Professor Steven Nissen - Lipoprotein(a): a new target for therapeutic intervention

▶︎
Latest Lipoprotein(a) Update: What it Means for You and Your Heart

▶︎
Lp(a): What We Should Know; Need to Know; and Hope to Know - CME

▶︎
